Literature DB >> 10841909

Clinical value of cystatin C determination.

M K Page1, J Bükki, P Luppa, D Neumeier.   

Abstract

It has been reported that cystatin C (cys-C) is elevated in patients with malignant disease. In order to investigate whether this phenomenon is linked to or independent of renal function, and at the same time examine the role of this marker in other pathological situations, cys-C concentrations were compared with 24-h creatinine clearance values in three groups of patients; the first group were undergoing treatment for malignant disease, the second group were renal transplant patients and the third randomly taken from patients for whom a routine creatinine clearance had been requested. Several patients with malignant disease had high cys-C levels without any correspondence to creatinine clearance values. Additionally, although cys-C shows a high sensitivity for detecting impaired glomerular function in renal transplant patients, the specificity was very low, with little discrimination being observed between patients with normal and pathological creatinine clearance levels. In other patients both the sensitivity and specificity of cys-C could be shown to be very good. Thus although cys-C can generally be recommended as a marker of the glomerular filtration rate, there are some patients for whom the clinical relevance is unclear.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841909     DOI: 10.1016/s0009-8981(00)00234-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Serum levels of cystatin C in patients with malignancy.

Authors:  Keiko Nakai; Masayuki Kikuchi; Keiko Fujimoto; Yoshito Kaneko; So Omori; Kenji Nakai; Akira Suwabe
Journal:  Clin Exp Nephrol       Date:  2008-03-05       Impact factor: 2.801

2.  Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury.

Authors:  Longxiang Su; Lixin Xie; Dawei Liu
Journal:  Crit Care       Date:  2015-07-14       Impact factor: 9.097

3.  Influence of point mutations on the stability, dimerization, and oligomerization of human cystatin C and its L68Q variant.

Authors:  Aneta Szymańska; Elżbieta Jankowska; Marta Orlikowska; Izabela Behrendt; Paulina Czaplewska; Sylwia Rodziewicz-Motowidło
Journal:  Front Mol Neurosci       Date:  2012-07-27       Impact factor: 5.639

4.  Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting.

Authors:  Seung Hyun Lee; Young-Nam Youn; Hyun Chel Choo; Sak Lee; Kyung-Jong Yoo
Journal:  Heart       Date:  2015-07-27       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.